Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.51
+0.32 (2.43%)
Dec 20, 2024, 4:00 PM EST - Market closed

Wave Life Sciences Revenue

Wave Life Sciences had revenue of $-7.68M in the quarter ending September 30, 2024, a decrease of -115.60%. This brings the company's revenue in the last twelve months to $53.61M, down -37.29% year-over-year. In the year 2023, Wave Life Sciences had annual revenue of $113.31M with 3,005.10% growth.

Revenue (ttm)
$53.61M
Revenue Growth
-37.29%
P/S Ratio
31.64
Revenue / Employee
$200,037
Employees
268
Market Cap
2.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023113.31M109.66M3,005.10%
Dec 31, 20223.65M-37.32M-91.09%
Dec 31, 202140.96M20.89M104.03%
Dec 31, 202020.08M4.09M25.61%
Dec 31, 201915.98M1.57M10.89%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PACS Group 3.56B
Alignment Healthcare 2.47B
Premier 1.33B
Omnicell 1.06B
Supernus Pharmaceuticals 651.97M
TransMedics Group 401.09M
Mirum Pharmaceuticals 307.03M
Tarsus Pharmaceuticals 129.62M
Revenue Rankings